MTMR9

Across TCGA pan-cancer cohorts, MTMR9 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MTMR9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MTMR9 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types MTMR9 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, LUAD, and LSCC are the cancer types where MTMR9 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTMR9 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.454	<.001	9	view →
LUAD	Female	II,III,IV	−0.344	<.001	9	view →
LSCC	Male	II,III,IV	−0.263	<.001	8	view →
PDAC	All	II,III,IV	+0.222	.001	6	view →
HNSC	Female	All	+0.160	.047	3	view →
OV	All	All	−0.417	.012	2	view →
CCRCC	All	III,IV	−0.081	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MTMR9–COAD

Open the COAD breakdown →